Topical photodynamic therapy (PDT) is commonly used in the treatment of nonmelanoma skin cancer and is favoured for ease of administration, tolerability and excellent cosmetic outcome. Treatment involves topical application of a prodrug, aminolaevulinic acid (ALA) or its methyl ester MAL, which is converted to the photosensitiser protoporphyrin (Pp) IX.
Light-activation of PpIX initiates production of reactive oxygen species (ROS) and target cell death primarily via apoptosis.
1 Treatment takes some hours as sufficient time must be given for prodrug penetration and PpIX accumulation, and efficacy is dependent on treatment protocol, type and site of target lesion(s). 
